Juodawlkis A - Search Results

1

Anti-HBV specific beta-L-2'-deoxynucleosides.

Bryant ML, Bridges EG, Placidi L, Faraj A, Loi AG, Pierra C, Dukhan D, Gosselin G, Imbach JL, Hernandez B, Juodawlkis A, Tennant B, Korba B, Cote P, Cretton-Scott E, Schinazi RF, Sommadossi JP. Bryant ML, et al. Among authors: juodawlkis a. Nucleosides Nucleotides Nucleic Acids. 2001 Apr-Jul;20(4-7):597-607. doi: 10.1081/NCN-100002336. Nucleosides Nucleotides Nucleic Acids. 2001. PMID: 11563077 Review.

2

Antiviral L-nucleosides specific for hepatitis B virus infection.

Bryant ML, Bridges EG, Placidi L, Faraj A, Loi AG, Pierra C, Dukhan D, Gosselin G, Imbach JL, Hernandez B, Juodawlkis A, Tennant B, Korba B, Cote P, Marion P, Cretton-Scott E, Schinazi RF, Sommadossi JP. Bryant ML, et al. Among authors: juodawlkis a. Antimicrob Agents Chemother. 2001 Jan;45(1):229-35. doi: 10.1128/AAC.45.1.229-235.2001. Antimicrob Agents Chemother. 2001. PMID: 11120971 Free PMC article.

3

Antiviral beta-L-nucleosides specific for hepatitis B virus infection.

Standring DN, Bridges EG, Placidi L, Faraj A, Loi AG, Pierra C, Dukhan D, Gosselin G, Imbach JL, Hernandez B, Juodawlkis A, Tennant B, Korba B, Cote P, Cretton-Scott E, Schinazi RF, Myers M, Bryant ML, Sommadossi JP. Standring DN, et al. Among authors: juodawlkis a. Antivir Chem Chemother. 2001;12 Suppl 1:119-29. Antivir Chem Chemother. 2001. PMID: 11594678

4

Synthesis and biological evaluation of 2',3'-didehydro-2',3'- dideoxy-5-fluorocytidine (D4FC) analogues: discovery of carbocyclic nucleoside triphosphates with potent inhibitory activity against HIV-1 reverse transcriptase.

Shi J, McAtee JJ, Schlueter Wirtz S, Tharnish P, Juodawlkis A, Liotta DC, Schinazi RF. Shi J, et al. Among authors: juodawlkis a. J Med Chem. 1999 Mar 11;42(5):859-67. doi: 10.1021/jm980510s. J Med Chem. 1999. PMID: 10072683

5

Carboranyl oligonucleotides. 3. Biochemical properties of oligonucleotides containing 5-(o-carboranyl-1-yl)-2'-deoxyuridine.

Lesnikowski ZJ, Fulcrand G, Lloyd RM Jr, Juodawlkis A, Schinazi RF. Lesnikowski ZJ, et al. Among authors: juodawlkis a. Biochemistry. 1996 May 7;35(18):5741-6. doi: 10.1021/bi953078e. Biochemistry. 1996. PMID: 8639534

6

In-vitro activities of paromomycin and lasalocid evaluated in combination against Cryptosporidium parvum.

You X, Schinazi RF, Arrowood MJ, Lejkowski M, Juodawlkis AS, Mead JR. You X, et al. Among authors: juodawlkis as. J Antimicrob Chemother. 1998 Feb;41(2):293-6. doi: 10.1093/jac/41.2.293. J Antimicrob Chemother. 1998. PMID: 9533476

7

A rapid non-culture-based assay for clinical monitoring of phenotypic resistance of human immunodeficiency virus type 1 to lamivudine (3TC).

García Lerma J, Schinazi RF, Juodawlkis AS, Soriano V, Lin Y, Tatti K, Rimland D, Folks TM, Heneine W. García Lerma J, et al. Among authors: juodawlkis as. Antimicrob Agents Chemother. 1999 Feb;43(2):264-70. doi: 10.1128/AAC.43.2.264. Antimicrob Agents Chemother. 1999. PMID: 9925516 Free PMC article.

8

Treatment of isografted 9L rat brain tumors with beta-5-o-carboranyl-2'-deoxyuridine neutron capture therapy.

Schinazi RF, Hurwitz SJ, Liberman I, Juodawlkis AS, Tharnish P, Shi J, Liotta DC, Coderre JA, Olson J. Schinazi RF, et al. Among authors: juodawlkis as. Clin Cancer Res. 2000 Feb;6(2):725-30. Clin Cancer Res. 2000. PMID: 10690559

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

8 results

Search Page

Filters